Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Kim, Sue Y ^a   Yoon, Jiyeon ^a   Ko, Young S ^a   Chang, Mee S ^a   Park, Jong Wan ^a   Lee, Hee E ^a   Kim, Min A ^a   Kim, Ji H ^b   Kim, Woo H ^a   Lee, Byung L ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Angiogenesis; Gastric cancer; Immunohistochemistry; PFOXO1; Tissue array analysis

Indexed keywords

BETA CATENIN; CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN KINASE B; SHORT HAIRPIN RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR FKHR; VASCULOTROPIN; ANGIOGENIC PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; RNA; SMALL INTERFERING RNA; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LENTIVIRINAE; MICROVASCULATURE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; STOMACH CARCINOMA; TUMOR VASCULARIZATION; WESTERN BLOTTING; BIOSYNTHESIS; CARCINOMA; DRUG ANTAGONISM; FEMALE; GASTRECTOMY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING; STOMACH TUMOR; TUMOR CELL LINE; VASCULARIZATION;

ANGIOGENIC PROTEINS; CARCINOMA; CELL LINE, TUMOR; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GASTRECTOMY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; STOMACH NEOPLASMS;

EID: 79959339173     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-264     Document Type: Article

References (36)

1. Maiese K, Chong ZZ, Shang YC, Hou J. Clever cancer strategies with FoxO transcription factors. Cell Cycle 2008, 7:3829-3839. 10.4161/cc.7.24.7231, 2630379, 19066462.
2. Vogt PK, Jiang H, Aoki M. Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins. Cell Cycle 2005, 4:908-913. 10.4161/cc.4.7.1796, 15917664.
3. Roy SK, Srivastava RK, Shankar S. Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal 2010, 5:10. 10.1186/1750-2187-5-10, 2915986, 20642839.
4. Huang H, Tindall DJ. Dynamic FoxO transcription factors. J Cell Sci 2007, 120:2479-2487. 10.1242/jcs.001222, 17646672.
5. Yang JY, Hung MC. A new fork for clinical application: targeting forkhead transcription factors in cancer. Clin Cancer Res 2009, 15:752-757. 10.1158/1078-0432.CCR-08-0124, 2676228, 19188143.
6. Modur V, Nagarajan R, Evers BM, Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002, 277:47928-47937. 10.1074/jbc.M207509200, 12351634.
7. Ciechomska I, Pyrzynska B, Kazmierczak P, Kaminska B. Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells. Oncogene 2003, 22:7617-7627. 10.1038/sj.onc.1207137, 14576824.
8. Lentzsch S, Chatterjee M, Gries M, Bommert K, Gollasch H, Dörken B, Bargou RC. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells. Leukemia 2004, 18:1883-1890. 10.1038/sj.leu.2403486, 15356648.
9. Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, Lam EW, Burgering BM. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 2002, 22:2025-2036. 10.1128/MCB.22.7.2025-2036.2002, 133681, 11884591.
10. Furuyama T, Kitayama K, Shimoda Y, Ogawa M, Sone K, Yoshida-Araki K, Hisatsune H, Nishikawa S, Nakayama K, Nakayama K, Ikeda K, Motoyama N, Nori N. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 2004, 279:34741-34749. 10.1074/jbc.M314214200, 15184386.
11. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher A, Kollipara R, DePinho RA, Zeiher AM, Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005, 115:2382-2392. 10.1172/JCI23126, 1184037, 16100571.
12. Dansen TB, Burgering BM. Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol 2008, 18:421-429. 10.1016/j.tcb.2008.07.004, 18715783.
13. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
14. Kim JH, Kim MK, Lee HE, Cho SJ, Cho YJ, Lee BL, Lee HS, Nam SY, Lee JS, Kim WH. Constitutive phosphorylation of the FOXO1A transcription factor as a prognostic variable in gastric cancer. Mod Pathol 2007, 20:835-842. 10.1038/modpathol.3800789, 17491598.
15. Lee HS, Lee HK, Kim HS, Yang HK, Kim WH. Tumor suppressor gene expression correlates with gastric cancer prognosis. J Pathol 2003, 200:39-46. 10.1002/path.1288, 12692839.
16. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 2001, 92:1427-1434. 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L, 11745219.
17. Lee BL, Kim WH, Jung J, Cho SJ, Park JW, Kim J, Chung HY, Chang MS, Nam SY. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 2008, 29:44-51.
18. Hong SS, Lee H, Kim KW. HIF-1α: a valid therapeutic target for tumor therapy. Cancer Res Treat 2004, 36:343-353. 10.4143/crt.2004.36.6.343, 2843877, 20368827.
19. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994, 79:185-188. 10.1016/0092-8674(94)90187-2, 7525076.
20. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31. 10.1038/nm0195-27, 7584949.
21. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995, 36:169-180. 10.1007/BF00666038, 8534865.
22. Yoshino S, Kato M, Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 1995, 2:156-160. 10.1111/j.1442-2042.1995.tb00445.x, 8536130.
23. Delahunt B, Bethwaite PB, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol 1997, 80:401-404.
24. Herbst C, Kosmehl H, Stiller KJ, Berndt A, Eiselt M, Schubert J, Katenkamp D. Evaluation of microvessel density by computerized image analysis in human renal cell carcinoma. Correlation to pT category, nuclear grade, proliferative activity and occurrence of metastasis. J Cancer Res Clin Oncol 1998, 124:141-147. 10.1007/s004320050147, 9619739.
25. Lee JS, Jung JJ, Kim J. Quantification of angiogenesis by a computerized image analysis system in renal cell carcinoma. Analyt Quant Cytol Histol 2000, 22:469-474.
26. Stoeltzing O, McCarty MF, Wey JS, Fan F, Liu W, Belcheva A, Bucana CD, Semenza GL, Ellis LM. Role of hypoxia-inducible factor 1α in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 2004, 96:946-956. 10.1093/jnci/djh168, 15199114.
27. Sharma SG, Aggarwal N, Gupta SD, Singh MK, Gupta R, Dinda AK. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors. Int Urol Nephrol 2010, 43:125-129.
28. Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. World J Gastroenterol 2002, 8:591-595.
29. Zhao ZS, Zhou JL, Yao GY, Ru GQ, Ma J, Ruan J. Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas. World J Gastroenterol 2005, 11:3227-3233.
30. Ma J, Zhang L, Ru GQ, Zhao ZS, Xu WJ. Upregulation of hypoxia inducible factor 1α mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World J Gastroenterol 2007, 13:1680-1686.
31. Liu N, Zhang LH, Du H, Hu Y, Zhang GG, Wang XH, Li JY, Ji JF. Overexpression of endothelial cell specific molecule-1 (ESM-1) in gastric cancer. Ann Surg Oncol 2010, 17:2628-2639. 10.1245/s10434-010-1037-9, 20383661.
32. Yang Q, Ye ZY, Zang JX, Tao HQ, Li SG, Zhao ZS. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis. Anat Rec (Hoboken) 2010, 293:2012-2019.
33. Cabuk D, Basaran G, Celikel C, Dane F, Yumuk PF, Iyikesici MS, Ekenel M, Turhal NS. Vascular endothelial growth factor, hypoxia-inducible factor 1α and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival. Oncology 2007, 72:111-117.
34. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W, Yanai A, Ogura K, Omata M. Constitutive NF-κB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009, 15:2248-2258. 10.1158/1078-0432.CCR-08-1383, 19276252.
35. Ojesina AI. The role of β-catenin in regulating angiogenesis in Wilms tumor. J Pediatr Surg 2004, 39:1446-1447.
36. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008. 10.1038/sj.onc.1205260, 11960372.